Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Hong

Showing results (1201-1210 of 1,220) with videos related to

Pageof 122
Sort By:
Heliyon|July 11, 2024
Prevalence of subthreshold depression and its related factors in Chinese college students: A cross-sectional studyPu Ge, Cheng Tan, Jia-Xin Liu, et al.
Cancer Causes & Control : CCC|August 26, 2009
Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18Wen Chen, Xun Zhang, Anco Molijn, et al.
Aging|December 13, 2019
Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective studyPei-Yun Zhou, Chao-Ping Yang, Zheng Tang, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2017
Benzoxazolinone aryl sulfonamides as potent, selective Na<sub>v</sub>1.7 inhibitors with in vivo efficacy in a preclinical pain modelJoseph E Pero, Michael A Rossi, Hannah D G F Lehman, et al.
JCI Insight|June 21, 2022
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signalingLeila B Giron, Michael J Peluso, Jianyi Ding, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2017
Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na<sub>v</sub>1.7 inhibitors with pain efficacy in miceAnthony J Roecker, Melissa Egbertson, Kristen L G Jones, et al.
The Lancet. Infectious Diseases|June 30, 2026
Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trialHong-Xing Pan, Zhao-Feng Bi, Yu-Lin Jing, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 21, 2026
Oculomics and AI: The Eye as a biomarker for health spanJoy Le Yi Wong, Haoran Cheng, Wen Jun Peh, et al.
Nature Communications|January 20, 2024
Macro CD5L<sup>+</sup> deteriorates CD8<sup>+</sup>T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinomaJia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, et al.
World Journal of Gastrointestinal Oncology|December 11, 2023
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinomaSirish Dharmapuri, Umut Özbek, Hiren Jethra, et al.
Pageof 122

Showing results (1201-1210 of 1,220) with videos related to

Sort By:
Pageof 122
Heliyon|July 11, 2024
Prevalence of subthreshold depression and its related factors in Chinese college students: A cross-sectional studyPu Ge, Cheng Tan, Jia-Xin Liu, et al.
Cancer Causes & Control : CCC|August 26, 2009
Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18Wen Chen, Xun Zhang, Anco Molijn, et al.
Aging|December 13, 2019
Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective studyPei-Yun Zhou, Chao-Ping Yang, Zheng Tang, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2017
Benzoxazolinone aryl sulfonamides as potent, selective Na<sub>v</sub>1.7 inhibitors with in vivo efficacy in a preclinical pain modelJoseph E Pero, Michael A Rossi, Hannah D G F Lehman, et al.
JCI Insight|June 21, 2022
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signalingLeila B Giron, Michael J Peluso, Jianyi Ding, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2017
Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na<sub>v</sub>1.7 inhibitors with pain efficacy in miceAnthony J Roecker, Melissa Egbertson, Kristen L G Jones, et al.
The Lancet. Infectious Diseases|June 30, 2026
Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trialHong-Xing Pan, Zhao-Feng Bi, Yu-Lin Jing, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 21, 2026
Oculomics and AI: The Eye as a biomarker for health spanJoy Le Yi Wong, Haoran Cheng, Wen Jun Peh, et al.
Nature Communications|January 20, 2024
Macro CD5L<sup>+</sup> deteriorates CD8<sup>+</sup>T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinomaJia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, et al.
World Journal of Gastrointestinal Oncology|December 11, 2023
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinomaSirish Dharmapuri, Umut Özbek, Hiren Jethra, et al.
Pageof 122